See the Protaryx Medical device in action! Our innovative transseptal access system is designed to enhance precision, safety, and efficiency for left heart interventions. The Protaryx atraumatic extendable end effector redefines transseptal puncture with exceptional echogenicity with a gentle, atraumatic interface. This game-changing feature enhances echo visibility, eliminating the need for workaround techniques like "drag and drop" that compensate for poor imaging. With clear echogenic feedback, fluoroless procedures become a real possibility, while the improved visibility makes the device intuitive and easy to learn, significantly flattening the learning curve. Check out the animation and see how Protaryx is changing the game! #ProtaryxMedical #TransseptalAccess #Innovation #StructuralHeart #MedicalDevices"
关于我们
The Protaryx Transseptal Puncture Device is the next-generation solution for transseptal puncture, revolutionizing access to the left side of the heart via the fossa ovalis. This innovative device enables zero-exchange procedures, incorporates a proprietary RF guidewire technology compatible with standard electrosurgical generators. Its extendable, highly echogenic atraumatic probe results in superior workflow efficiency. These advanced features provide unparalleled precision, safety, and efficiency, making the system intuitive and accessible for operators of all experience levels.
- 网站
-
https://protaryx.com
Protaryx Medical的外部链接
- 所属行业
- 医疗设备
- 规模
- 2-10 人
- 总部
- Baltimore，Maryland
- 类型
- 私人持股
- 创立
- 2019
地点
-
主要
获取路线
323 W Camden St
Suite 600
US，Maryland，Baltimore，21201
Protaryx Medical员工
动态
-
We’re excited to share that Cardiac Rhythm News has published an article highlighting the first-in-human experience with the Protaryx Medical transseptal puncture device! Presented as a late-breaking trial at #STS2025, this study showcases how our innovative approach is redefining left heart access by enhancing precision, safety, and efficiency in transseptal procedures. Read the full article here: https://lnkd.in/e7jAtw-C A huge thank you to Rachael Quinn, PhD for presenting at STS and the entire team pushing the boundaries of transseptal innovation. #TransseptalInnovation #StructuralHeart #Cardiology #ProtaryxMedical #STS2025
-
Exciting News from Protaryx Medical! We’re thrilled to announce that Rachael Quinn, PhD, will be presenting our late-breaking research at the upcoming 2025 STS Conference! Presentation Title: "Late Breaking: Breaking Down Barriers to Left Heart Access: First-In-Human Experience with a Novel Transseptal Puncture Device" ?? When: Friday, January 24, 2025 ? Time: 2:00 PM – 2:07 PM PT ?? Where: 2025 STS Conference This landmark presentation highlights our first-in-human clinical experience with Protaryx’s novel device designed to revolutionize left heart access through innovative transseptal puncture technology. Join us as we take a significant step forward in advancing patient care and improving procedural efficiency for structural heart interventions. #Innovation #MedicalDevices #LeftHeartAccess #TransseptalPuncture #STS2025
-
Breaking News from Protaryx Medical! We are thrilled to announce a major milestone in our journey to revolutionize transseptal access. Protaryx Medical has successfully completed a First-in-Human study of our innovative transseptal puncture technology! This achievement represents a significant leap forward in advancing safer, more precise, and efficient procedures for structural heart interventions. The positive results from this study affirm the potential of our technology to empower clinicians and improve outcomes for patients worldwide. We extend our heartfelt gratitude to the dedicated clinical teams, trial participants, and everyone at Protaryx Medical who made this success possible. Your unwavering commitment to innovation and patient care drives our mission forward. Stay tuned as we continue to pave the way in transforming structural heart access solutions. This is just the beginning! #Innovation #Healthcare #MedTech #StructuralHeart #ProtaryxMedical #FirstInHuman